Literature DB >> 3905471

Effects of exogenous insulin on placental transfer of maternal glucose to the rat fetus.

X Testar, M A Lasunción, R Chieri, E Herrera.   

Abstract

There is controversy concerning the possible modulation of glucose transfer to the fetus by insulin acting on the maternal side of the placenta. To study this question, 20.5 day pregnant rats were infused simultaneously with (U-14C)-D-glucose (via the jugular vein) and with different doses of insulin (via the left uterine artery) so that placentas from the left uterine horn were exposed to a higher insulin concentration than those from the right uterine horn. Placentas and fetuses from each uterine side were processed separately. No differences were detected in total blood radioactivity, plasma-14C-glucose, -14-C-lactate, -glucose, or -radioimmunoassayable insulin in fetuses from the left versus the right uterine horn. Total placenta radioactivity and 14C-glycogen were also similar in the left and right uterine sides at all insulin doses studied. Infusion of insulin (66 mU/min) to the pregnant rat caused hyperinsulinaemia and hypoglycaemia, decreased blood total radioactivity and plasma 14C-glucose, and increased plasma 14C-lactate in the mother. The level of fetal plasma 14C-glucose paralleled that of the mother. It is concluded that in the rat, placental glucose uptake, its transfer to the fetus, and fetal glucose utilization are not directly affected by maternal circulating insulin. Metabolic changes occurring in fetuses of hyperinsulinaemic mothers are secondary to the decreased availability of glucose.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905471     DOI: 10.1007/bf00265022

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  37 in total

1.  Fetal metabolic response to maternal fasting in the rat.

Authors:  J R Girard; P Ferré; M Gilbert; A Kervran; R Assan; E B Marliss
Journal:  Am J Physiol       Date:  1977-05

2.  Effect of insulin on the materno-fetal transfer of glucose in the rat.

Authors:  F Rabain; L Picon
Journal:  Horm Metab Res       Date:  1974-09       Impact factor: 2.936

3.  Use of streptozotocin as diabetic agent in pregnant rats.

Authors:  S Sybulski; G B Maughan
Journal:  Endocrinology       Date:  1971-12       Impact factor: 4.736

4.  The effect of insulin on glucose metabolism of the incubated human placenta.

Authors:  A J Szabo; R D Grimaldi
Journal:  Am J Obstet Gynecol       Date:  1970-01-01       Impact factor: 8.661

5.  Nonuniform distribution and grouping of insulin receptors on the surface of human placental syncytial trophoblast.

Authors:  D M Nelson; R M Smith; L Jarett
Journal:  Diabetes       Date:  1978-05       Impact factor: 9.461

6.  Insulin and placenta: degradation and stabilization, binding to microvillous membrane receptors, and amino acid uptake.

Authors:  R B Steel; J D Mosley; C H Smith
Journal:  Am J Obstet Gynecol       Date:  1979-10-15       Impact factor: 8.661

7.  Liver and kidney cortex gluconeogenesis from L-alanine in fed and starved rats.

Authors:  A Zorzano; E Herrera
Journal:  Int J Biochem       Date:  1984

8.  Method for the study of metabolite transfer from rat mother to fetus.

Authors:  M A Lasunción; X Testar; M Palacín; R Chieri; E Herrera
Journal:  Biol Neonate       Date:  1983

9.  Effect of insulin on glucose uptake by the maternal hindlimb and uterus, and by the fetus in conscious pregnant sheep.

Authors:  W W Hay; J W Sparks; M Gilbert; F C Battaglia; G Meschia
Journal:  J Endocrinol       Date:  1984-01       Impact factor: 4.286

10.  Glucose metabolism, lactate, and ammonia production by the human placenta in vitro.

Authors:  I R Holzman; A F Philipps; F C Battaglia
Journal:  Pediatr Res       Date:  1979-02       Impact factor: 3.756

View more
  1 in total

Review 1.  Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia.

Authors:  Antonia Hufnagel; Laura Dearden; Denise S Fernandez-Twinn; Susan E Ozanne
Journal:  J Endocrinol       Date:  2022-04-05       Impact factor: 4.669

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.